Thea Cæcilie Viborg Vestergaard

Indikation for behandling med warfarin bør altid fremgå eksplicit ved sektorskifte

Publikation: Bidrag til tidsskrift/Konferencebidrag i tidsskrift /Bidrag til avisTidsskriftartikelForskningpeer review

  • Thea Vestergaard
  • Johanne Hjort, Institut for klinisk medicin, Aarhus universitet, Danmark
  • Henrik Bjørnsgaard Madsen, Medicinsk afdeling, Regionshospitalet Randers
  • ,
  • Jonas Agerlund Povlsen
  • ,
  • Bo Løfgren

Warfarin has a narrow therapeutic window and side effects include bleeding causing e.g. hospital admission and death. Monitoring of treatment and review of indication are mandatory. We report a case of more than four years of warfarin treatment without indication. Treatment was not discontinued due to inadequate medical record keeping and communication among health-care providers. Medical-record keeping should follow guidelines from the National Board of Health. In addition, clearly stated treatment duration and indication may prevent unwarranted or premature termination of treatment.

OriginalsprogDansk
TidsskriftUgeskrift for Laeger
Vol/bind176
Nummer47
ISSN0041-5782
StatusUdgivet - 17 nov. 2014

Se relationer på Aarhus Universitet Citationsformater

ID: 96452090